Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Protagonist Therapeutics Price to Sales Ratio 2015-2019 | PTGX

Historical PS ratio values for Protagonist Therapeutics (PTGX) over the last 10 years. The current P/S ratio for Protagonist Therapeutics as of December 05, 2019 is .
  
Protagonist Therapeutics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-12-05 7.64 0.00
2019-09-30 12.01 $-0.01 0.00
2019-06-30 12.11 $0.10 116.05
2019-03-31 12.57 $0.99 12.74
2018-12-31 6.73 $1.43 4.70
2018-09-30 10.29 $1.97 5.23
2018-06-30 6.72 $2.22 3.03
2018-03-31 8.59 $1.67 5.15
2017-12-31 20.80 $1.16 17.98
2017-09-30 17.67 $0.52 34.03
2017-06-30 11.31 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.221B $0.031B
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.968B 16.01
CSL (CSLLY) Australia $86.243B 0.00
Gilead Sciences (GILD) United States $84.448B 10.46
Vertex Pharmaceuticals (VRTX) United States $57.578B 58.77
Biogen (BIIB) United States $52.242B 8.97
Illumina (ILMN) United States $46.993B 51.56
Regeneron Pharmaceuticals (REGN) United States $40.620B 17.79
Alexion Pharmaceuticals (ALXN) United States $25.548B 12.62
Incyte (INCY) United States $20.463B 47.50
Seattle Genetics (SGEN) United States $20.283B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.057B 0.00
Genmab (GNMSF) Denmark $14.991B 66.21
BioMarin Pharmaceutical (BMRN) United States $14.602B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.600B 0.00
Galapagos (GLPG) Belgium $11.277B 29.06
Exact Sciences (EXAS) United States $10.777B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.449B 30.81
BeiGene (BGNE) Cayman Islands $9.241B 0.00
Bio-Techne Corp (TECH) United States $8.323B 55.71
Sarepta Therapeutics (SRPT) United States $8.303B 0.00
Amarin (AMRN) Ireland $8.137B 0.00
Moderna (MRNA) United States $7.088B 0.00
Guardant Health (GH) United States $7.039B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.820B 0.00
Medicines (MDCO) United States $6.702B 0.00
Reata Pharmaceuticals (RETA) United States $6.193B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.110B 15.53
ARGENX SE-ADR (ARGX) Netherlands $5.754B 0.00
Exelixis (EXEL) United States $5.369B 15.10
Ascendis Pharma (ASND) Denmark $4.898B 0.00
BioNTech SE (BNTX) Germany $4.835B 0.00
Repligen (RGEN) United States $4.613B 83.59
China Biologic Products (CBPO) China $4.606B 25.94
Bluebird Bio (BLUE) United States $4.488B 0.00
Spark Therapeutics (ONCE) United States $4.237B 0.00
Mirati Therapeutics (MRTX) United States $4.164B 0.00
MorphoSys AG (MOR) Germany $4.062B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.980B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.851B 0.00
Blueprint Medicines (BPMC) United States $3.695B 0.00
Immunomedics (IMMU) United States $3.482B 0.00
Adaptive Biotechnologies (ADPT) United States $3.378B 0.00
Alkermes (ALKS) Ireland $3.344B 0.00
Genmab (GMAB) Denmark $3.108B 6.40
MyoKardia (MYOK) United States $3.101B 0.00
Halozyme Therapeutics (HALO) United States $2.853B 0.00
UniQure (QURE) Netherlands $2.852B 0.00
Emergent Biosolutions (EBS) United States $2.794B 27.75
Amicus Therapeutics (FOLD) United States $2.739B 0.00
NeoGenomics (NEO) United States $2.709B 144.17
Acceleron Pharma (XLRN) United States $2.594B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.463B 0.00
Zai Lab (ZLAB) China $2.374B 0.00
Arena Pharmaceuticals (ARNA) United States $2.354B 5.47
RA PHARMCTL INC (RARX) United States $2.209B 0.00
Insmed (INSM) United States $2.087B 0.00
Myriad Genetics (MYGN) United States $1.921B 28.39
Ligand Pharmaceuticals (LGND) United States $1.889B 36.35
Dicerna Pharmaceuticals (DRNA) United States $1.841B 0.00
Denali Therapeutics (DNLI) United States $1.743B 0.00
Zymeworks (ZYME) Canada $1.737B 0.00
Akcea Therapeutics (AKCA) United States $1.731B 0.00
REGENXBIO (RGNX) United States $1.652B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.641B 0.00
Editas Medicine (EDIT) United States $1.579B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.520B 0.00
Epizyme (EPZM) United States $1.440B 0.00
Sangamo Therapeutics (SGMO) United States $1.356B 0.00
Alector (ALEC) United States $1.352B 0.00
Innoviva (INVA) United States $1.324B 3.90
Arvinas (ARVN) United States $1.314B 0.00
Coherus BioSciences (CHRS) United States $1.283B 0.00
Athenex (ATNX) United States $1.248B 0.00
WAVE Life Sciences (WVE) Singapore $1.212B 0.00
Principia Biopharma (PRNB) United States $1.184B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.130B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.073B 0.00
Zealand Pharma (ZEAL) Denmark $1.041B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.958B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.915B 7.69
Codexis (CDXS) United States $0.897B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.864B 0.00
Intellia Therapeutics (NTLA) United States $0.864B 0.00
Precision BioSciences (DTIL) United States $0.845B 0.00
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Vericel (VCEL) United States $0.839B 312.75
Anika Therapeutics (ANIK) United States $0.814B 26.42
MiMedx (MDXG) United States $0.813B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Twist Bioscience (TWST) United States $0.772B 0.00
Heska (HSKA) United States $0.752B 192.20
Revance Therapeutics (RVNC) United States $0.749B 0.00
Adverum Biotechnologies (ADVM) United States $0.732B 0.00
ANI Pharmaceuticals (ANIP) United States $0.726B 12.39
DBV Technologies S.A (DBVT) France $0.726B 0.00
Cara Therapeutics (CARA) United States $0.682B 0.00
Clovis Oncology (CLVS) United States $0.664B 0.00
UROGEN PHARMA (URGN) United States $0.652B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.639B 0.00
Mesoblast (MESO) Australia $0.625B 0.00
Cellectis S.A (CLLS) France $0.619B 0.00
BioDelivery Sciences (BDSI) United States $0.600B 0.00
Sorrento Therapeutics (SRNE) United States $0.599B 0.00
GENFIT S.A (GNFT) France $0.594B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Cytokineticsorporated (CYTK) United States $0.579B 0.00
Retrophin (RTRX) United States $0.570B 0.00
Intra-Cellular Therapies (ITCI) United States $0.552B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Kadmon Holdings (KDMN) United States $0.543B 0.00
Agenus (AGEN) United States $0.541B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 12.09
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.492B 0.00
Stemline Therapeutics (STML) United States $0.487B 0.00
Dynavax Technologies (DVAX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.401B 2.77
Merus (MRUS) Netherlands $0.397B 0.00
AnaptysBio (ANAB) United States $0.392B 0.00
Bellus Health (BLU) Canada $0.386B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.363B 0.00
Arcus Biosciences (RCUS) United States $0.363B 0.00
Puma Biotechnology (PBYI) United States $0.349B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
Pfenex (PFNX) United States $0.344B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
OSMOTICA PHARM (OSMT) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.335B 8.37
Avid Bioservices (CDMO) United States $0.324B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Kindred Biosciences (KIN) United States $0.300B 0.00
Geron (GERN) United States $0.298B 0.00
CytomX Therapeutics (CTMX) United States $0.296B 0.00
Kamada (KMDA) Israel $0.293B 8.56
Cue Biopharma (CUE) United States $0.290B 0.00
Compugen (CGEN) Israel $0.281B 0.00
Albireo Pharma (ALBO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.260B 0.00
MannKind (MNKD) United States $0.256B 0.00
Sutro Biopharma (STRO) United States $0.254B 0.00
ADMA Biologics Inc (ADMA) United States $0.251B 0.00
Scholar Rock Holding (SRRK) United States $0.248B 0.00
Inovio Pharmaceuticals (INO) United States $0.247B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
Exicure (XCUR) United States $0.230B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
Theratechnologies (THTX) Canada $0.223B 0.00
Senesco Technologies (ELOX) United States $0.219B 0.00
Spero Therapeutics (SPRO) United States $0.217B 0.00
ChromaDex (CDXC) United States $0.217B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.216B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.210B 0.00
Athersys (ATHX) United States $0.205B 0.00
Syros Pharmaceuticals (SYRS) United States $0.201B 0.00
Mersana Therapeutics (MRSN) United States $0.200B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.197B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.187B 0.00
Palatin Technologies (PTN) United States $0.186B 5.09
Affimed (AFMD) Germany $0.178B 0.00
ARAVIVE, INC (ARAV) United States $0.176B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Dyadic (DYAI) United States $0.163B 0.00
Cerecor (CERC) United States $0.163B 0.00
CorMedix Inc (CRMD) United States $0.155B 0.00
Alcobra (ARCT) United States $0.153B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
NantKwest (NK) United States $0.151B 0.00
VBI Vaccines (VBIV) United States $0.147B 0.00
Fortress Biotech (FBIO) United States $0.146B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
TELA Bio (TELA) United States $0.145B 0.00
Proteostasis Therapeutics (PTI) United States $0.143B 0.00
Prometic Life Sciences (LMNL) Canada $0.140B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Enzo Biochem (ENZ) United States $0.131B 0.00
Novavax (NVAX) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Arbutus Biopharma (ABUS) Canada $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Arsanis (XFOR) United States $0.127B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Celyad SA (CYAD) Belgium $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
BioTime (LCTX) United States $0.123B 6.31
AVEO Pharmaceuticals (AVEO) United States $0.121B 0.00
OvaScience (MLND) United States $0.105B 0.00
Emmaus Life Sciences (EMMA) United States $0.103B 0.00
Verastem (VSTM) United States $0.102B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.098B 2.62
Aduro Biotech (ADRO) United States $0.096B 0.00
Menlo Therapeutics (MNLO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.088B 0.00
Acorda Therapeutics (ACOR) United States $0.088B 0.00
Antibe Therapeutics (ATBPF) Canada $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Liquidia Technologies (LQDA) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Trevena (TRVN) United States $0.062B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.059B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
Protalix BioTherapeutics (PLX) Israel $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Alimera Sciences (ALIM) United States $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Soligenix (SNGX) United States $0.021B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Advaxis (ADXS) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00